GenSpera
GenSpera, Inc. (OTC:QB GNSZ) is a development-stage pharmaceutical company based in San Antonio, Texas. The company is focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature. The company also holds patents on prodrug candidates that target the prostate-specific enzymes Prostate Specific Antigen (PSA) and Human Glandular Kallikrein (hK2). These candidates are expected to be useful in the treatment of prostate cancer.
primaryTopic
GenSpera
GenSpera, Inc. (OTC:QB GNSZ) is a development-stage pharmaceutical company based in San Antonio, Texas. The company is focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature. The company also holds patents on prodrug candidates that target the prostate-specific enzymes Prostate Specific Antigen (PSA) and Human Glandular Kallikrein (hK2). These candidates are expected to be useful in the treatment of prostate cancer.
has abstract
GenSpera, Inc. (OTC:QB GNSZ) i ...... as well as cancer stem cells.
@en
founding year
industry
key person
location city
number of employees
type
Link from a Wikipage to an external page
Wikipage page ID
31.257.653
Wikipage revision ID
743.662.958
founder
*Craig Dionne, PhD
*John Isaacs, PhD
*Samuel Denmeade, MD
location country
logo size
traded as
subject
comment
GenSpera, Inc. (OTC:QB GNSZ) i ...... treatment of prostate cancer.
@en
label
GenSpera
@en
wasDerivedFrom
isPrimaryTopicOf
name
GenSpera, Inc.
@en